Barrington Research Maintains Outperform on Stride, Lowers Price Target to $115
Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and lowers the price target from $125 to $115.
Share
Why It Matters
An analyst still likes Stride but thinks the stock price might be lower. This shows the company is solid, but maybe not as exciting as before.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.